ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Interleukin-2 and Interleukin-12 in Treating Patients With Refractory or Advanced Solid Tumors

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00020163


Locations
United States, Maryland
NCI - Center for Cancer Research    
      Bethesda, Maryland, United States, 20892
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support    
      Bethesda, Maryland, United States, 20892-1182

Sponsors and Collaborators
National Cancer Institute (NCI)

Investigators
Study Chair:     John E. Janik, MD     NCI - Metabolism Branch;MET    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers